Brown Advisory’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$195M Sell
721,553
-14,667
-2% -$4.37M 0.32% 68
2025
Q4
$243M Sell
736,220
-47,399
-6% -$16.1M 0.34% 63
2025
Q3
$271M Sell
783,619
-19,189
-2% -$5.8M 0.35% 61
2025
Q2
$250M Buy
802,808
+105,832
+15% +$40.4M 0.33% 59
2025
Q1
$365M Sell
696,976
-10,569
-1% -$5.4M 0.52% 49
2024
Q4
$358M Buy
707,545
+13,157
+2% +$7.48M 0.45% 52
2024
Q3
$406M Sell
694,388
-3,804
-0.5% -$2.15M 0.51% 50
2024
Q2
$356M Buy
698,192
+21,660
+3% +$10.6M 0.46% 51
2024
Q1
$335M Sell
676,532
-1,602,004
-70% -$814M 0.45% 54
2023
Q4
$1.2B Sell
2,278,536
-134,372
-6% -$71.7M 1.69% 11
2023
Q3
$1.22B Buy
2,412,908
+156,068
+7% +$76.8M 2% 8
2023
Q2
$1.08B Buy
2,256,840
+287,706
+15% +$141M 1.69% 11
2023
Q1
$931M Buy
1,969,134
+84,813
+5% +$40.9M 1.58% 12
2022
Q4
$999M Sell
1,884,321
-233,640
-11% -$124M 1.86% 8
2022
Q3
$1.07B Buy
2,117,961
+203,873
+11% +$107M 2.08% 9
2022
Q2
$983M Sell
1,914,088
-275,115
-13% -$138M 1.85% 10
2022
Q1
$1.12B Sell
2,189,203
-99,245
-4% -$47.9M 1.66% 12
2021
Q4
$1.15B Buy
2,288,448
+181,371
+9% +$82.1M 1.42% 14
2021
Q3
$823M Buy
2,107,077
+202,912
+11% +$84M 1.22% 15
2021
Q2
$763M Sell
1,904,165
-42,605
-2% -$17M 1.15% 21
2021
Q1
$724M Buy
1,946,770
+94,691
+5% +$32.8M 1.24% 21
2020
Q4
$649M Buy
1,852,079
+194,047
+12% +$65M 1.15% 22
2020
Q3
$517M Buy
1,658,032
+198,781
+14% +$61.1M 1.07% 28
2020
Q2
$430M Buy
1,459,251
+145,392
+11% +$41.7M 1% 30
2020
Q1
$328M Buy
1,313,859
+108,747
+9% +$29.9M 1% 31
2019
Q4
$354M Buy
1,205,112
+49,672
+4% +$13M 0.9% 34
2019
Q3
$251M Buy
1,155,440
+83,250
+8% +$20.1M 0.7% 39
2019
Q2
$262M Buy
1,072,190
+39,927
+4% +$9.6M 0.75% 37
2019
Q1
$255M Buy
1,032,263
+19,045
+2% +$4.86M 0.72% 37
2018
Q4
$252M Sell
1,013,218
-16,502
-2% -$4.36M 0.85% 33
2018
Q3
$274M Buy
1,029,720
+44,339
+4% +$11.5M 0.78% 36
2018
Q2
$242M Buy
985,381
+102,824
+12% +$24.7M 0.74% 36
2018
Q1
$189M Sell
882,557
-285,977
-24% -$65.3M 0.61% 42
2017
Q4
$258M Buy
1,168,534
+463,714
+66% +$98.3M 0.82% 36
2017
Q3
$138M Buy
704,820
+13,934
+2% +$2.69M 0.46% 54
2017
Q2
$128M Buy
690,886
+25,710
+4% +$4.51M 0.39% 61
2017
Q1
$109M Buy
665,176
+28,688
+5% +$4.7M 0.37% 64
2016
Q4
$102M Buy
636,488
+35,824
+6% +$5.35M 0.36% 64
2016
Q3
$84.1M Buy
600,664
+63,363
+12% +$8.87M 0.29% 72
2016
Q2
$75.9M Buy
537,301
+126,531
+31% +$16.9M 0.27% 73
2016
Q1
$52.9M Sell
410,770
-5,751
-1% -$680K 0.18% 88
2015
Q4
$49M Sell
416,521
-21,501
-5% -$2.51M 0.17% 97
2015
Q3
$50.8M Sell
438,022
-9,291
-2% -$1.11M 0.18% 89
2015
Q2
$54.6M Sell
447,313
-24,773
-5% -$2.93M 0.18% 85
2015
Q1
$55.8M Buy
472,086
+6,688
+1% +$743K 0.18% 89
2014
Q4
$47M Buy
465,398
+455
+0.1% +$43.1K 0.15% 107
2014
Q3
$40.1M Buy
464,943
+1,737
+0.4% +$147K 0.13% 117
2014
Q2
$37.9M Sell
463,206
-3,913
-0.8% -$308K 0.12% 125
2014
Q1
$38.3M Buy
467,119
+370,506
+383% +$27.9M 0.12% 120
2013
Q4
$7.28M Buy
96,613
+3,511
+4% +$252K 0.02% 280
2013
Q3
$6.67M Buy
93,102
+7,299
+9% +$522K 0.02% 281
2013
Q2
$5.62M Buy
+85,803
New +$5.34M 0.02% 291

Other funds holding UNH

Brown Advisory's UNH Position: Q1 2026 in Review

Brown Advisory reduced its UnitedHealth (UNH) stake by 2% in Q1 2026, selling an estimated $4.37M and leaving 721,553 shares worth $195M. The position accounts for 0.32% of the portfolio, ranked #68.

Brown Advisory first reported a position in UNH in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.22B in Q3 2023. 3,020 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Brown Advisory held 721,553 shares of UnitedHealth worth $195M as of Q1 2026.
  • Brown Advisory sold 14,667 UnitedHealth shares in Q1 2026, an estimated $4.37M.
  • UnitedHealth made up 0.32% of Brown Advisory's portfolio in Q1 2026, its #68 holding.
  • Brown Advisory first reported a position in UnitedHealth in Q2 2013 and has held it in 52 quarters since.
  • Brown Advisory's UnitedHealth position peaked at $1.22B in Q3 2023.
  • 3,020 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Brown Advisory's 13F filing for Q1 2026, filed 15 May 2026.